Deaths of elderly individuals wrongly given an extra dose of the vaccine

A 103-year-old woman was erroneously given a fourth dose of the Covid-19 vaccine by a mobile vaccination team, soon after her 3rd shot. The woman, a nursing home resident, was admitted to a hospital on Dec 16 - three days after receiving the extra dose. She had pneumonia and low sodium levels and was subsequently diagnosed as having had a stroke. She died on Jan. 10th, 2022.

------------------

An 88-year-old male, survivor of COVID-19, was given 3rd dose of Moderna Covid Vaccine in error, shortly after the 2nd dose (1st dose was administered 2 months after his COVID-19 infection).  Next morning he was noted to act strange and was found unresponsive less than 2hrs after.  He was hospitalized and intubated. A few days later the family made the decision to remove him from the ventilator. He died on March 16, 2021

------------------

A 93-year-old male fell ill on the day of his vaccination, 3rd dose of Pfizer vaccine. He died 2 days later. Cause of death: vaccine dosage error.

----------------

 A 72-year-old male received the first dose of BNT162B2 on March 3rd, 2021, the second dose of BNT162B2 on March 31, 2021 and the third dose of BNT162B2 on May 17th 2021. Medical history included ongoing autoimmune myasthenia gravis and post-smoking chronic obstructive pulmonary disease (COPD). The patient experienced COVID-19 confirmed by positive PCR test on Aug 2nd, 2021. The main clinical signs were as follows: On Jul 30, 2021, the patient was asthenic. A few days later, there was an increase in asthenia with deterioration of general condition. On August 10, 2021, he experienced dyspnea, cough and breathing difficulties with 90% ambient air saturation. CT scan was suggestive of COVID-19 pneumonia with extensive involvement of the anomalies. He was hospitalized. On Aug. 11, 2021, his oxygenation was at 6l / min, saturation was at 88%. He was moved to intensive care. Immune plasma treatment started. Serology showed antibodies against SARS COv-2. IgG: 8.12. The patient died on August 14th, 2021

----------------

A 70-year-old male received his 1st dose of BNT162B2 on April 21, 2021, 2nd dose on May 5th, 2021 and the 3rd dose on June 2, 2021 (since he was refused a vaccine passport because of shorter interval between the first two doses). Approximately 12 hours after vaccination with this third dose, he developed an acute fever (38.5C), and mental confusion followed by shortness of breath and loss of consciousness. The patient died on the same day he was administered the 3rd dose,  June 2, 2021,  as a result of a lethal heart arrhythmia (asystole). 


REFERENCES

https://www.straitstimes.com/singapore/health/moh-investigating-death-of-103-year-old-woman-who-was-erroneously-given-fourth-covid-19-vaccine-shot

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1155891

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1090417

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1642143

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1449237


Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis ...
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an incr...
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high ...
Read more